IAFNF (Life & Health Insurance) Stock Valuation & Fair Value Trading above fair value
IAFNF (Life & Health Insurance) trades at a blended P/E of 15.1, about 29% above its historical normal valuation, with a forward growth estimate of 10.3% and a PEG of 1.47. Analysts' one-year estimates have been hit 73% of the time.
No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation, forecast return and analyst accuracy only. Ratings that cite business quality require one.
- Price $150.54 at the 2026-09-23 close, 3.5% above the 20-day average ($145.48) and 3.8% above the 50-day ($145.06).
- RSI (14) at 73.3.
- 52-week range $105.25 to $151.52: the price is 0.6% below the high and 43.0% above the low.
Valuation flags
- Overvalued by 29%
- Overbought (RSI 73)
Verdict history
tickerseer's rating has been trading above fair value since 2026-09-19.
Ratings recorded live since 2026-09-21. Earlier points apply today's valuation rules to the metrics tickerseer archived that week.
Frequently asked questions
Is IAFNF overvalued?
At a blended P/E of 15.1 versus its historical normal P/E of 11.7, IAFNF trades about 29% above its typical valuation, with a PEG of 1.47 on 10.3% forward growth. tickerseer currently rates it trading above fair value.
What is IAFNF's fair value and PEG?
IAFNF trades at a blended P/E of 15.1 against a historical normal P/E of 11.7, a PEG of 1.47, and a forward growth estimate of 10.3%.
Has tickerseer's rating of IAFNF changed?
tickerseer's rating has been trading above fair value since 2026-09-19.
Industry: Life & Health Insurance. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.